The DOI matches its Crossref record.
Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro.
Open accessAbstract
Human recombinant transforming growth factor alpha (TGF alpha), which binds to the epidermal growth factor (EGF) receptor and causes several biological effects similar to those caused by EGF, was compared with murine EGF for its effects on a number of parameters of bone cell metabolism. TGF alpha stimulated bone resorption in two organ culture systems, the fetal rat long bone and neonatal mouse calvarial systems. TGF alpha stimulated bone resorption at concentrations as low as 0.1 ng/ml. TGF alpha effects on bone resorption in mouse calvariae were inhibited by indomethacin, suggesting that, like EGF, its effects were mediated by prostaglandin synthesis. TGF alpha had a different time course of action on bone resorption from that of EGF, causing more rapid release of previously incorporated 45Ca from bone cultures, suggesting that TGF alpha does not function on bone as a simple EGF analogue. TGF alpha also caused effects on osteoblast function resembling those of EGF. It inhibited alkaline phosphatase activity in cultured rat osteosarcoma cells with the osteoblast phenotype and inhibited collagen synthesis in fetal rat calvaria at concentrations of 1.0 ng/ml. The lowest concentration of TGF alpha (expressed as nanogram equivalents of EGF per ml) required to produce a response in all of the systems tested was about 1/10th of that needed for EGF to produce a similar effect. These results indicate that TGF alpha is a potent stimulator of bone resorption and inhibitor of bone formation as assessed by inhibition of collagen synthesis and alkaline phosphatase activity and are consistent with the hypothesis that TGF alpha may be responsible, at least in part, for the bone resorption associated with some tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Transforming Growth Factor-α: a More Potent Angiogenic Mediator than Epidermal Growth Factor
Schreiber, A. B., Winkler, M. E., & Derynck, R. (1986) · Science · doi:10.1126/science.2422759 · Cited by 838
Self-citationSandgren, E. P., Luetteke, N. C., Palmiter, R. D., Brinster, R. L., & Lee, D. C. (1990) · Cell · doi:10.1016/0092-8674(90)90075-p · Cited by 752
Barrandon, Y., & Green, H. (1987) · Cell · doi:10.1016/0092-8674(87)90179-6 · Cited by 694
Paria, B. C., & Dey, S. K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4756 · Cited by 681
Local and Systemic Factors in the Pathogenesis of Osteoporosis
Epstein, F. H., & Raisz, L. G. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803313181305 · Cited by 493
Bone cell biology: The regulation of development, structure, and function in the skeleton
Marks, S. C., & Popoff, S. N. (1988) · American Journal of Anatomy · doi:10.1002/aja.1001830102 · Cited by 477
Guise, T. A., & Mundy, G. R. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0323 · Cited by 472
Self-citationThe epidermal growth factor receptor ligands at a glance
Schneider, M. R., & Wolf, E. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21635 · Cited by 447
Metabolism and Effects of Epidermal Growth Factor and Related Growth Factors in Mammals*
FISHER, D. A., & LAKSHMANAN, J. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-3-418 · Cited by 374
The type 1 (EGFR-related) family of growth factor receptors and their ligands
Prigent, S. A., & Lemoine, N. R. (1992) · Progress in Growth Factor Research · doi:10.1016/0955-2235(92)90002-y · Cited by 369
The role of the EGFR signaling in tumor microenvironment
De Luca, A., Carotenuto, A., Rachiglio, A., Gallo, M., Maiello, M. R., Aldinucci, D., Pinto, A., & Normanno, N. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21260 · Cited by 359
Lu, X., Wang, Q., Hu, G., Van Poznak, C., Fleisher, M., Reiss, M., Massagué, J., & Kang, Y. (2009) · Genes & Development · doi:10.1101/gad.1824809 · Cited by 304
The Physiology Of Transforming Growth Factor-α
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60289-4 · Cited by 258
Interleukin-1β is a potent inhibitor of bone formation in vitro
Dr. Stashenko, P., Dewhirst, F. E., Rooney, M. L., Desjardins, L. A., & Heeley, J. D. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020612 · Cited by 255
The Epidermal Growth Factor Family
Carpenter, G., & Wahl, M. I. (1991) · Peptide Growth Factors and Their Receptors I · doi:10.1007/978-1-4612-3210-0_4 · Cited by 253
van der Stegen, S. J. C., Davies, D. M., Wilkie, S., Foster, J., Sosabowski, J. K., Burnet, J., Whilding, L. M., Petrovic, R. M., Ghaem-Maghami, S., Mather, S., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301523 · Cited by 126
“promoting bone resorption in mice (35) and is as active as mouse EGF in accelerating eyelid opening in newborn mice (31).”
Background
Metadata
- Authors
- Ibbotson, K. J., Harrod, J., Gowen, M., D'Souza, S., Smith, D. D., Winkler, M. E., Derynck, R., & Mundy, G. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1986-04
- Volume
- 83
- Issue
- 7
- Pages
- 2228-2232
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2050438549
- Cited by
- 179
- References
- 0
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.